Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Dr. Arevitalize vs MEDGm

Dr. Arevitalize
Graded #236

Higher grade

vs+6.1
MEDGm
Graded #380

Lower grade

The verdict

Dr. Arevitalize takes it — 65.2/100 to 59.1/100.

Dr. Arevitalize grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Dr. Arevitalize (Dr.Arevitalize Health, Inc.) is a LegitScript-certified telehealth platform offering compounded GLP-1 weight-loss medication in both injectable and oral-capsule forms — semaglutide from $269/mo and tirzepatide from $349/mo, sold in 1-, 3-, 6-, and 12-month bundles.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueDr. Arevitalize +4
39
35
Dose & formulationEven
75
75
Clinical oversightDr. Arevitalize +11
71
60
Labs & monitoringDr. Arevitalize +37
88
51
FulfillmentMEDGm +14
72
86
Contract termsMEDGm +12
55
67
Dr. Arevitalize · left barMEDGm · right bar

The numbers

MetricDr. ArevitalizeMEDGm
WeighScore65.2/10059.1/100
GradeCC
Scorecard rank#236#380
Semaglutide$319/mo (compounded)$299/mo (standing rate; $179 covers the first month only, after an auto-applied coupon)
Tirzepatide$359/mo (compounded)$399/mo (standing rate; $279 covers the first month only)
CoverageCoverage not publishedAll 50 states plus Washington, D.C.
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Dr. Arevitalize

Graded #236 · C

Strengths

  • Offers both injectable and oral-capsule compounded GLP-1 — a needle-free option many providers do not carry
  • Semaglutide from $269/mo and tirzepatide from $349/mo, in 1-, 3-, 6-, and 12-month bundles
  • LegitScript-certified; clinician-guided with lab/bloodwork analysis and personalized plans
  • Intro pricing on injectable semaglutide ($269, was $319) and oral semaglutide ($299, was $349)

Where it loses points

  • Compounded GLP-1s are not FDA-approved finished products
  • Compounding pharmacy partner and prescribing clinician are not named on the site
  • State availability is not published on the site
MEDGm

Graded #380 · C

Strengths

  • Names four dispensing pharmacies with street addresses and phone numbers
  • States its compounding class — produced in state-licensed 503A or FDA-registered facilities — rather than leaving it unsaid
  • Coverage is 50 states plus the District of Columbia and the intake's own state selector agrees with the Terms, which is rarer than it should be
  • Refills and shipping are described as included, with no separate shipping line at checkout
  • Prices an oral semaglutide lane alongside both injections

Where it loses points

  • No price is visible until a sixteen-screen quiz ending in name, email and phone number has been completed
  • $179 and $279 are first-month rates produced by an auto-applied coupon; the standing month-to-month rates are $299 and $399
  • The treatments FAQ says “your price never increases, even as your dose goes up” on a plan whose price increases at the first renewal
  • The twelve-month bundle auto-renews for another full upfront charge of $2,028 or $3,228, billed up to ten days early, and nothing is refundable once taken
  • The funnel prints “prescription plan approved” and a 100% success probability before any payment and before a clinician has seen the intake, beside a twenty-minute timer that resets on reload
  • Zepbound, Wegovy and Ozempic have cards on the GLP-1 page and all six links lead to the quiz; the post-intake funnel contains none of those names
  • No principal place of business is published — only a Delaware state of formation
  • No clinician is named and no NPI appears anywhere; the site names professional entities only

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 536 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard